Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medican Enterprises Inc. was a bio-pharmaceutical company primarily focused on the medical cannabis industry. Through its subsidiary, Medican Technologies Inc., the company aimed to develop and commercialize pharmaceutical-grade cannabis products and proprietary extraction and cultivation technologies. Its business model involved establishing a network of production facilities and research centers to provide standardized cannabinoid-based therapies for various medical conditions. However, the company has faced significant operational and regulatory challenges and is currently considered an inactive shell entity in the over-the-counter markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medican Technologies.